Green Seaweed Caulerpa racemosa as a Novel Non-Small Cell Lung Cancer Inhibitor in Overcoming Tyrosine Kinase Inhibitor Resistance: An Analysis Employing Network Pharmacology, Molecular Docking, and In Vitro Research

Vincent Lau,Fahrul Nurkolis,Moon Nyeo Park,Didik Setyo Heriyanto,Nurpudji Astuti Taslim,Trina Ekawati Tallei,Happy Kurnia Permatasari,Raymond R. Tjandrawinata,Seungjoon Moon,Bonglee Kim

DOI: https://doi.org/10.3390/md22060272

2024-06-13

Marine Drugs

Abstract:The marine environment provides a rich source of distinct creatures containing potentially revolutionary bioactive chemicals. One of these organisms is Caulerpa racemosa, a type of green algae known as green seaweed, seagrapes, or green caviar. This organism stands out because it has great promise for use in medicine, especially in the study of cancer. Through the utilization of computational modeling (in silico) and cellular laboratory experiments (in vitro), the chemical components included in the green seaweed C. racemosa were effectively analyzed, uncovering its capability to treat non-small cell lung cancer (NSCLC). The study specifically emphasized blocking SRC, STAT3, PIK3CA, MAPK1, EGFR, and JAK1 using molecular docking and in vitro. These proteins play a crucial role in the EGFR Tyrosine Kinase Inhibitor Resistance pathway in NSCLC. The chemical Caulersin (C2) included in C. racemosa extract (CRE) has been identified as a potent and effective agent in fighting against non-small cell lung cancer (NSCLC), both in silico and in vitro. CRE and C2 showed a level of inhibition similar to that of osimertinib (positive control/NSCLC drug).

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

The paper attempts to address the issue of drug resistance in the treatment of non-small cell lung cancer (NSCLC). Specifically, the researchers explored the potential of the green alga Caulerpa racemosa (hereinafter referred to as CR) as a potential NSCLC inhibitor through network pharmacology, molecular docking, and in vitro experiments, particularly its potential in overcoming resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. ### Main Research Content: 1. **Compound Identification**: Through untargeted metabolomics analysis, 8 potential compounds in CR extract (CRE) were identified. 2. **Pharmacological and Toxicity Analysis**: These compounds were subjected to Pa value, toxicity calculation analysis, drug-likeness analysis, and network pharmacology analysis to evaluate their anticancer potential and safety. 3. **Molecular Docking**: Molecular docking simulations were conducted to assess the binding ability of these compounds to key proteins (such as SRC, STAT3, PIK3CA, MAPK1, EGFR, JAK1, etc.). 4. **In Vitro Experiments**: In vitro experiments were conducted in NSCLC cell lines to evaluate the anticancer effects and safety of CRE and its main compound C2. ### Research Findings: - **Compound C2 (Caulersin)**: Showed the highest binding affinity, particularly notable in proteins related to EGFR tyrosine kinase inhibitor resistance. - **Safety**: CRE and its main compound C2 exhibited low toxicity in normal cells, demonstrating good selectivity and safety. - **In Vitro Effects**: CRE and C2 significantly inhibited the expression of key proteins (such as SRC, STAT3, PIK3CA, MAPK1, EGFR, JAK1) in NSCLC cells, with effects comparable to the positive control drug osimertinib. ### Conclusion: The study confirmed through various methods the potential of CR extract and its main compound C2 in overcoming EGFR tyrosine kinase inhibitor resistance in NSCLC, providing a theoretical basis for their development as novel anticancer drugs.

Green Seaweed Caulerpa racemosa as a Novel Non-Small Cell Lung Cancer Inhibitor in Overcoming Tyrosine Kinase Inhibitor Resistance: An Analysis Employing Network Pharmacology, Molecular Docking, and In Vitro Research

Pro-Apoptotic Activity and Cell Cycle Arrest of Caulerpa sertularioides against SKLU-1 Cancer Cell in 2D and 3D Cultures

Elucidation of anti-human melanoma and anti-aging mechanisms of compounds from green seaweed Caulerpa racemosa

Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway

Identification and functional analysis of phycocyanin-derived bioactive peptides with non-small cell lung cancer cell inhibition

From Marine Origin to Therapeutics: The Antitumor Potential of Marine Algae-Derived Compounds

High throughput virtual screening and validation of Plant-Based EGFR L858R kinase inhibitors against Non-Small cell lung Cancer: An integrated approach Utilizing GC-MS, network Pharmacology, Docking, and molecular dynamics

Unveiling promising phytocompounds from Moringa oleifera as dual inhibitors of EGFR(T790M/C797S) and VEGFR-2 in non-small cell lung cancer through in silico screening, ADMET, dynamics simulation, and DFT analysis

Ulvophyte Green Algae Caulerpa lentillifera: Metabolites Profile and Antioxidant, Anticancer, Anti-Obesity, and In Vitro Cytotoxicity Properties

A Novel Anticancer Peptide Derived from Bryopsis plumosa Regulates Proliferation and Invasion in Non-Small Cell Lung Cancer Cells

Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach

Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling

Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer

From Sea to Science: Coral Aquaculture for Sustainable Anticancer Drug Development

Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance

The Ethyl Acetate Extract from Celastrus Orbiculatus Suppresses Non-Small-cell Lung Cancer by Activating Hippo Signaling and Inhibiting YAP Nuclear Translocation.

Caulerpa taxifolia inhibits cell proliferation and induces oxidative stress in breast cancer cells

The molecular mechanisms of Caulophyllum robustum Maxim extract inhibition by regulating FAK/PI3K signaling pathway in gastric cancer HGC-27 cells

Active and machine learning-enhanced discovery of new FGFR3 inhibitor, Rhapontin, through virtual screening of receptor structures and anti-cancer activity assessment

Identification of a Novel Autophagic Inhibitor Cepharanthine to Enhance the Anti-Cancer Property of Dacomitinib in Non-Small Cell Lung Cancer.

Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule